Kevin Phelan, MD
Surgery · Apo, APNPI 1497012488
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (46.5%), food and beverage and education — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 90.6% of it on its own, with 7 other manufacturers making up the rest. 2024 is the largest year on record at $1,830, 7.0 times the $262 reported in 2020.
Across 47 payments — averaging $107.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$5K
- Integra Lifesciences Corporation$229
- Stryker$131
- Biotissue Holdings Inc.$31
- Takeda Pharmaceuticals U.S.A., Inc.$27
- Smith+Nephew$23
- plus $32 from 2 others
What the payments were for
- Travel & lodging$2,34246%
- Food & beverage$1,68934%
- Education$1,00020%
- Gifts$90%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 37 | $4,565 |
| Integra Lifesciences Corporation | 3 | $229 |
| Stryker | 1 | $131 |
| Biotissue Holdings Inc. | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Smith+Nephew | 1 | $23 |
| Davol Inc. | 1 | $18 |
| Endogastric Solutions, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$3,834
- INTEGRA$396
- OMNIGRAFT$198
- SURGIMEND$198
- INTEGRA DERMAL REGENERATION TEMPLATE$198
- 1788$131
How this compares
Too few surgery providers in APto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron Hcl | 32 | $182 |
| Oxycodone Hcl | 34 | $116 |
Paid to pharmacies, not to this prescriber.
Other surgery in Apo
- Harry AubinApo$8K
- Aaron LaneApo$3K
- Justin LarocqueApo$313
- Benjamin DuddyApo$272
- Christopher NgApo$174
- Joy LiangApo$125
- Max ChaeApo$91
- Caroline CahillFpo$607
- David SamahaFpo$308
- William IsomFpo$57
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.